Literature DB >> 25898921

Are all the previously reported genetic variants in limb girdle muscular dystrophy genes pathogenic?

Giuseppina Di Fruscio1,2, Arcomaria Garofalo1,2, Margherita Mutarelli2, Marco Savarese1,2, Vincenzo Nigro1,2.   

Abstract

Hundreds of variants in autosomal genes associated with the limb girdle muscular dystrophies (LGMDs) have been reported as being causative. However, in most cases the proof of pathogenicity derives from their non-occurrence in hundreds of healthy controls and/or from segregation studies in small families. The limited statistics of the genetic variations in the general population may hamper a correct interpretation of the effect of variants on the protein. To clarify the meaning of low-frequency variants in LGMD genes, we have selected all variants described as causative in the Leiden Open Variation Database and the Human Gene Mutation Database. We have systematically searched for their frequency in the NHLBI GO Exome Sequencing Project (ESP) and in our internal database. Surprisingly, the ESP contains about 4% of the variants previously associated with a dominant inheritance and about 9% of those associated with a recessive inheritance. The putative disease alleles are much more frequent than those estimated considering the disease prevalence. In conclusion, we hypothesize that a number of disease-associated variants are non-pathogenic and that other variations are not fully penetrant, even if they affect the protein function, suggesting a more complex genetic mechanisms for such heterogeneous disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25898921      PMCID: PMC4519526          DOI: 10.1038/ejhg.2015.76

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  20 in total

1.  MutationTaster evaluates disease-causing potential of sequence alterations.

Authors:  Jana Marie Schwarz; Christian Rödelsperger; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2010-08       Impact factor: 28.547

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

Review 3.  Limb-girdle and congenital muscular dystrophies: current diagnostics, management, and emerging technologies.

Authors:  Carolina Tesi Rocha; Eric P Hoffman
Journal:  Curr Neurol Neurosci Rep       Date:  2010-07       Impact factor: 5.081

4.  LOVD v.2.0: the next generation in gene variant databases.

Authors:  Ivo F A C Fokkema; Peter E M Taschner; Gerard C P Schaafsma; J Celli; Jeroen F J Laros; Johan T den Dunnen
Journal:  Hum Mutat       Date:  2011-02-22       Impact factor: 4.878

Review 5.  Update on the genetics of limb girdle muscular dystrophy.

Authors:  Satomi Mitsuhashi; Peter B Kang
Journal:  Semin Pediatr Neurol       Date:  2012-12       Impact factor: 1.636

Review 6.  Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches.

Authors:  Vincenzo Nigro; Stefania Aurino; Giulio Piluso
Journal:  Curr Opin Neurol       Date:  2011-10       Impact factor: 5.710

7.  High prevalence of genetic variants previously associated with LQT syndrome in new exome data.

Authors:  Lena Refsgaard; Anders G Holst; Golnaz Sadjadieh; Stig Haunsø; Jonas B Nielsen; Morten S Olesen
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

8.  Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Christelle Golzio; Satu Sandell; Helena Luque; Mark Screen; Kristin McDonald; Jeffrey M Stajich; Ibrahim Mahjneh; Anna Vihola; Olayinka Raheem; Sini Penttilä; Sara Lehtinen; Sanna Huovinen; Johanna Palmio; Giorgio Tasca; Enzo Ricci; Peter Hackman; Michael Hauser; Nicholas Katsanis; Bjarne Udd
Journal:  Nat Genet       Date:  2012-02-26       Impact factor: 38.330

9.  New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants.

Authors:  Charlotte Andreasen; Jonas B Nielsen; Lena Refsgaard; Anders G Holst; Alex H Christensen; Laura Andreasen; Ahmad Sajadieh; Stig Haunsø; Jesper H Svendsen; Morten S Olesen
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

10.  Next-generation sequencing identifies transportin 3 as the causative gene for LGMD1F.

Authors:  Annalaura Torella; Marina Fanin; Margherita Mutarelli; Enrico Peterle; Francesca Del Vecchio Blanco; Rossella Rispoli; Marco Savarese; Arcomaria Garofalo; Giulio Piluso; Lucia Morandi; Giulia Ricci; Gabriele Siciliano; Corrado Angelini; Vincenzo Nigro
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more
  10 in total

Review 1.  The current state of clinical interpretation of sequence variants.

Authors:  Derick C Hoskinson; Adrian M Dubuc; Heather Mason-Suares
Journal:  Curr Opin Genet Dev       Date:  2017-01-31       Impact factor: 5.578

Review 2.  Limb-girdle muscular dystrophies - international collaborations for translational research.

Authors:  Rachel Thompson; Volker Straub
Journal:  Nat Rev Neurol       Date:  2016-04-01       Impact factor: 42.937

3.  Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy.

Authors:  Marius Kuhn; Dieter Gläser; Pushpa Raj Joshi; Stephan Zierz; Stephan Wenninger; Benedikt Schoser; Marcus Deschauer
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

4.  Retrospective analysis and reclassification of DYSF variants in a large French series of dysferlinopathy patients.

Authors:  Théo Charnay; Véronique Blanck; Mathieu Cerino; Marc Bartoli; Florence Riccardi; Nathalie Bonello-Palot; Christophe Pécheux; Karine Nguyen; Nicolas Lévy; Svetlana Gorokhova; Martin Krahn
Journal:  Genet Med       Date:  2021-04-29       Impact factor: 8.822

Review 5.  Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases.

Authors:  Christine Péladeau; Jagdeep K Sandhu
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

6.  The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States.

Authors:  Hemakumar M Reddy; Kyung-Ah Cho; Monkol Lek; Elicia Estrella; Elise Valkanas; Michael D Jones; Satomi Mitsuhashi; Basil T Darras; Anthony A Amato; Hart Gw Lidov; Catherine A Brownstein; David M Margulies; Timothy W Yu; Mustafa A Salih; Louis M Kunkel; Daniel G MacArthur; Peter B Kang
Journal:  J Hum Genet       Date:  2016-10-06       Impact factor: 3.172

7.  Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients.

Authors:  Jakub Piotr Fichna; Anna Macias; Marcin Piechota; Michał Korostyński; Anna Potulska-Chromik; Maria Jolanta Redowicz; Cezary Zekanowski
Journal:  Hum Genomics       Date:  2018-07-03       Impact factor: 4.639

8.  Prevalence of clinically actionable disease variants in exceptionally long-lived families.

Authors:  Paige Carlson; Mary K Wojczynski; Todd Druley; Joseph H Lee; Joseph M Zmuda; Bharat Thyagarajan
Journal:  BMC Med Genomics       Date:  2020-04-10       Impact factor: 3.063

9.  Fibrinogen as a Pleiotropic Protein Causing Human Diseases: The Mutational Burden of Aα, Bβ, and γ Chains.

Authors:  Elvezia Maria Paraboschi; Stefano Duga; Rosanna Asselta
Journal:  Int J Mol Sci       Date:  2017-12-14       Impact factor: 5.923

Review 10.  Is Gene-Size an Issue for the Diagnosis of Skeletal Muscle Disorders?

Authors:  Marco Savarese; Salla Välipakka; Mridul Johari; Peter Hackman; Bjarne Udd
Journal:  J Neuromuscul Dis       Date:  2020
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.